Abstract

The interpretation of genomic variants has become one of the paramount challenges in the post-genome sequencing era. In this review we summarize nearly 20 years of research on the applications of information theory (IT) to interpret coding and non-coding mutations that alter mRNA splicing in rare and common diseases. We compile and summarize the spectrum of published variants analyzed by IT, to provide a broad perspective of the distribution of deleterious natural and cryptic splice site variants detected, as well as those affecting splicing regulatory sequences. Results for natural splice site mutations can be interrogated dynamically with Splicing Mutation Calculator, a companion software program that computes changes in information content for any splice site substitution, linked to corresponding publications containing these mutations. The accuracy of IT-based analysis was assessed in the context of experimentally validated mutations. Because splice site information quantifies binding affinity, IT-based analyses can discern the differences between variants that account for the observed reduced (leaky) versus abolished mRNA splicing. We extend this principle by comparing predicted mutations in natural, cryptic, and regulatory splice sites with observed deleterious phenotypic and benign effects. Our analysis of 1727 variants revealed a number of general principles useful for ensuring portability of these analyses and accurate input and interpretation of mutations. We offer guidelines for optimal use of IT software for interpretation of mRNA splicing mutations.

Highlights

  • Pre-mRNA splicing is a necessary step in the production of a functional protein product

  • Alternative splicing is not generated by changes in the unspliced RNA sequence, whereas mutations that produce non-constitutive splice forms are the result of dysregulation of natural splice site recognition

  • A broad range of molecular phenotypes are possible depending on the type and severity of the mutation, making it imperative to understand the consequences of splicing mutations

Read more

Summary

18 Nov 2014

Any reports and responses or comments on the article can be found at the end of the article. All figure and table titles have been adjusted to reflect the order in which they appear in the main text We structured the article to enable readers to find and read particular sections of interest, without having familiarity with all of the preceding material

Introduction
23. Schneider TD
40. Tribus M
48. Green MR
Findings
69. Graveley BR
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.